Clinical Trial Results:
A multicenter, randomized, double-blind, double dummy, placebo controlled
crossover study, to investigate the 24 hour FEV1 profile of a single dose of QMF Twisthaler® (500/400 μg o.d.) delivered in the evening in adult patients with persistent asthma using fluticasone propionate/salmeterol (250/50 μg b.i.d.) as an active control.
Summary
|
|
EudraCT number |
2007-003192-39 |
Trial protocol |
BE |
Global completion date |
12 Apr 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Apr 2016
|
First version publication date |
03 Apr 2016
|
Other versions |
|
Summary report(s) |
CQMF149A2202_CT_gov_results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.